lexicon pharmaceuticals fda approval:UPDATE
UPDATE
2023年6月15日—(Nasdaq:LXRX)todayannouncedthattheU.S.FoodandDrugAdministration(FDA)hasapprovedINPEFA™(sotagliflozin),aonce-dailyoraltablet ...。其他文章還包含有:「AfterFDAMissinDiabetes」、「LEXICONANNOUNCESFDAAPPROVALOFINPEFA...」、「LexiconAnnouncesFDAApprovalofINPEFA™...」、「LexiconfinallyscoresFDAnodforheartfailuredrugInpefa」、「LexicongetsFDAapprovalforInpefatotreatheartfailure」、「Lex...
查看更多 離開網站After FDA Miss in Diabetes
https://medcitynews.com
Lexicon Pharmaceuticals drug Inpefa is now FDA-approved for heart failure. Inpefa is third in its class, but the biotech says its pill can reach ...
LEXICON ANNOUNCES FDA APPROVAL OF INPEFA ...
https://www.aspconline.org
(Nasdaq: LXRX) today announced that the U.S. Food and Drug Administration (FDA) has approved INPEFA™ (sotagliflozin), a once-daily oral tablet ...
Lexicon Announces FDA Approval of INPEFA™ ...
https://www.globenewswire.com
(Nasdaq: LXRX) today announced that the U.S. Food and Drug Administration (FDA) has approved INPEFA™ (sotagliflozin), a once-daily oral tablet ...
Lexicon finally scores FDA nod for heart failure drug Inpefa
https://www.fiercepharma.com
After setbacks, Lexicon's SGLT1/SGLT2 inhibitor Inpefa has gained an FDA approval to reduce the risk of heart failure.
Lexicon gets FDA approval for Inpefa to treat heart failure
https://www.pharmaceutical-tec
Lexicon Pharma Secures Key FDA Approval
https://seekingalpha.com
Lexicon Pharmaceuticals received FDA approval to market its heart failure drug Inpefa, as well as a broad label compared to rivals like ...
U.S. FDA approves Lexicon Pharma's drug for heart failure
https://www.reuters.com
The oral drug, sotagliflozin, is the company's first to be approved by the U.S. health agency and will be sold under the brand name Inpefa. It ...
US FDA approves Lexicon Pharma's drug for heart failure
https://health.economictimes.i
US FDA approves Lexicon Pharma's drug for heart failure. The oral drug, sotagliflozin, is the company's first to be approved by the US health ...